Pennant Competitors
| PNTG Stock | USD 31.16 0.45 1.42% |
Pennant vs Kura Oncology Correlation
Very good diversification
The correlation between Pennant Group and KURA is -0.42 (i.e., Very good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Pennant Group and KURA in the same portfolio, assuming nothing else is changed.
Moving together with Pennant Stock
Moving against Pennant Stock
| 0.6 | SPI | Spire Healthcare | PairCorr |
| 0.54 | S00 | Spire Healthcare | PairCorr |
| 0.41 | REG | Regis Healthcare | PairCorr |
| 0.37 | FLGT | Fulgent Genetics | PairCorr |
| 0.33 | PHA | Premier Health | PairCorr |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Pennant's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Pennant Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Pennant and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Pennant and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Pennant Group does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Pennant Stock performing well and Pennant Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Pennant's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| AMN | 2.46 | 0.13 | 0.04 | 0.40 | 2.19 | 4.49 | 33.09 | |||
| CRMD | 3.09 | (0.50) | 0.00 | (0.37) | 0.00 | 5.52 | 39.40 | |||
| IART | 2.09 | (0.28) | 0.00 | (0.07) | 0.00 | 4.58 | 15.12 | |||
| SNDA | 1.13 | 0.04 | 0.02 | 0.13 | 1.11 | 3.04 | 8.37 | |||
| BCAX | 2.91 | (0.05) | (0.02) | (0.01) | 3.17 | 6.05 | 19.25 | |||
| EYPT | 3.24 | 0.31 | 0.06 | (5.46) | 3.38 | 6.24 | 23.49 | |||
| PROK | 3.82 | (0.59) | 0.00 | (0.24) | 0.00 | 6.82 | 22.38 | |||
| INNV | 4.18 | 0.74 | 0.18 | 0.47 | 3.81 | 7.78 | 41.58 | |||
| HSTM | 1.05 | (0.36) | 0.00 | (0.70) | 0.00 | 1.97 | 8.53 | |||
| KURA | 2.87 | (0.32) | 0.00 | (0.23) | 0.00 | 5.01 | 22.83 |
Cross Equities Net Income Analysis
Compare Pennant Group and related stocks such as AMN Healthcare Services, CorMedix, and Integra LifeSciences Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AMN | (5.2 M) | (26.3 M) | 17.1 M | 32.9 M | 33.2 M | 81.9 M | 105.8 M | 132.6 M | 141.7 M | 114 M | 70.7 M | 327.4 M | 444.1 M | 210.7 M | (147 M) | (169 M) | (160.6 M) |
| CRMD | (9 M) | (6.7 M) | (3.4 M) | (9.1 M) | (20.5 M) | (18.2 M) | (24.6 M) | (33 M) | (26.8 M) | (16.4 M) | (22 M) | (28.2 M) | (29.7 M) | (46.3 M) | (17.9 M) | (16.1 M) | (16.9 M) |
| IART | (25.4 M) | 28 M | 41.2 M | (17 M) | 34 M | (3.5 M) | 74.6 M | 64.7 M | 60.8 M | 50.2 M | 133.9 M | 169.1 M | 180.6 M | 67.7 M | (6.9 M) | (8 M) | (7.6 M) |
| SNDA | 3.7 M | 3 M | (3.1 M) | (16.5 M) | (24.1 M) | (14.3 M) | (28 M) | (44.2 M) | (53.6 M) | (36 M) | (295.4 M) | 125.6 M | (54.4 M) | (21.1 M) | (2.1 M) | (1.9 M) | (1.9 M) |
| BCAX | (37.8 M) | (37.8 M) | (37.8 M) | (37.8 M) | (37.8 M) | (37.8 M) | (37.8 M) | (37.8 M) | (37.8 M) | (37.8 M) | (37.8 M) | (37.8 M) | (37.8 M) | (52 M) | (68 M) | (61.2 M) | (64.3 M) |
| EYPT | (2.3 M) | (8.6 M) | (24.8 M) | (11.9 M) | (13.4 M) | 6.3 M | (21.5 M) | (18.5 M) | (53.2 M) | (56.8 M) | (45.4 M) | (58.4 M) | (102.3 M) | (70.8 M) | (130.9 M) | (117.8 M) | (111.9 M) |
| PROK | (79.6 M) | (79.6 M) | (79.6 M) | (79.6 M) | (79.6 M) | (79.6 M) | (79.6 M) | (79.6 M) | (79.6 M) | (79.6 M) | (26.7 M) | (55.1 M) | (108 M) | (35.5 M) | (61.2 M) | (70.4 M) | (73.9 M) |
| INNV | (4.8 M) | (4.8 M) | (4.8 M) | (4.8 M) | (4.8 M) | (4.2 M) | (13.7 M) | (6.5 M) | 19.6 M | 26.3 M | (44 M) | (6.5 M) | (40.7 M) | (21.3 M) | (30.3 M) | (27.3 M) | (25.9 M) |
| HSTM | (4.5 M) | 6.9 M | 7.6 M | 8.4 M | 10.4 M | 8.6 M | 3.8 M | 10 M | 32.2 M | 15.8 M | 14.1 M | 5.8 M | 12.1 M | 15.2 M | 20 M | 23 M | 24.2 M |
| KURA | (33.6 K) | (22.4 K) | (27 K) | (27.3 K) | (11 M) | (22.6 M) | (27.6 M) | (35.4 M) | (60.4 M) | (63.1 M) | (89.6 M) | (130.5 M) | (135.8 M) | (152.6 M) | (174 M) | (156.6 M) | (148.8 M) |
Pennant Group and related stocks such as AMN Healthcare Services, CorMedix, and Integra LifeSciences Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Pennant Group financial statement analysis. It represents the amount of money remaining after all of Pennant Group operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Pennant Competitive Analysis
The better you understand Pennant competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Pennant's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Pennant's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Pennant Competition Performance Charts
Five steps to successful analysis of Pennant Competition
Pennant's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Pennant Group in relation to its competition. Pennant's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Pennant in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Pennant's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Pennant Group, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Pennant position
In addition to having Pennant in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Long Short Funds Thematic Idea Now
Long Short Funds
Funds or Etfs that are designed to hedge away market risk by investing in combination of bonds, stocks, derivative instruments as well as short positions to maximize returns irrespective of market conditions. The Long Short Funds theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Long Short Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Pennant Correlation with its peers. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Can Health Care Providers & Services industry sustain growth momentum? Does Pennant have expansion opportunities? Factors like these will boost the valuation of Pennant. Anticipated expansion of Pennant directly elevates investor willingness to pay premium valuations. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Pennant demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Quarterly Earnings Growth (0.15) | Earnings Share 0.75 | Revenue Per Share | Quarterly Revenue Growth 0.268 | Return On Assets |
The market value of Pennant Group is measured differently than its book value, which is the value of Pennant that is recorded on the company's balance sheet. Investors also form their own opinion of Pennant's value that differs from its market value or its book value, called intrinsic value, which is Pennant's true underlying value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Because Pennant's market value can be influenced by many factors that don't directly affect Pennant's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Pennant's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Pennant should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Pennant's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.